Immunopharmacology Flashcards

1
Q

What are the three main applications of immunosuppressants?

A
  1. Suppression of rejection to transplanted organs and tissue.
  2. Suppression of GVHD which arises from donor lymphocytes.
  3. Combat autoimmune diseases.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the tissues targeted by immunocompetent cells in donor grafts?

A

Liver, skin, mucosa, gut.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is rheumatoid arthritis?

A

Autoimmune disease primarily affecting the joints.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is lupus?

A

Multi-organ auto-immune disease characterized by rash on cheeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is ulcerative colitis?

A

T-cell infiltration and ulceration in the colon.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is psoriasis?

A

Auto-immune disease leading to scaly patches of skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the two main stages of the immune response?

A
  1. Induction phase.

2. Effector phase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two stages of of the induction phase?

A
  1. Antigen presentation.

2. Clonal expansion and maturation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain what happens in the antigen presentation stage:

A

Antigen presenting cell presents antigen to CD4 (Helper T-cell). This activates autocrine response in CD4 cells by releasing IL-2.

The helper T-cells then begin to divide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain what happens in the clonal expansion stage:

A

Helper T-cells differentiate into Th1 and Th2 cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do Th1 cells become?

A

Killer/helper T-cells that initiate cell-mediated responses against foreign/infected cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do Th2 cells become?

A

They activate B-cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do B-cells produce?

A

Antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do Th1 cells produce?

A

Cytokines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the five sites of immunosuppressant regulation?

A
  1. Inhibition of IL-2.
  2. Inhibition of cytokine gene expression.
  3. Cytotoxicity to kill immune cells.
  4. Inhibition of nucleic acid synthesis.
  5. Blockage of T-cell surface receptors to prevent antigen presentation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the calcineurin-NFAT pathway?

A

Pathway required by T-cell expansion; activate expression of IL-2 leading to activation and proliferation of T-cells.

17
Q

How is calcineurin activated?

A

Activation of T-cell receptors, causes dephosphorization of NFAT.

18
Q

What is the key detail of the cyclosporine mechanism?

A

Inhibition of calcineurin by the cyclophilin:cyclosporine complex to prevent NFAT-mediated gene transcription.

19
Q

What is the key detail of the tacromilus mechanism?

A

Inhibition of calcineurin by the FKBP:tacromilus complex to prevent NFAT-mediated gene transcription.

20
Q

What are proliferation signal inhibitors?

A

Drugs that interfere with downstream signals of IL-2 receptor activation.

21
Q

How is rapamycin different from tacromilus?

A

Rapamycin-FKBP complex does not inhibit calcineurin, it inhibits mTOR.

22
Q

What is mTOR?

A

mammalian target of rapamycine; responsible for promoting cell growth and proliferation.

23
Q

What are cytotoxic agents?

A

Drugs that lead to cross-linking of neighboring bases (interferes with DNA replication)

24
Q

What is the structure of antibodies?

A

2 Heavy chains
2 Light chains
Fab/Fc region

25
Q

What is the Fab region?

A

Determines antigen specificity

26
Q

What is the Fc region?

A

Determines antibody ‘class’ (recognized by different immune cells, leads to different responses)

27
Q

What is humanization/chimerization of antibodies?

A

Replacement of conserved regions of the mouse monoclonal antibody with corresponding sequences of human antibodies.

28
Q

How are therapeutic monoclonal antibodies named?

A
  • umab or -zumab for humanized.

- imab or -ximab for chimeric

29
Q

What is the mechanism of Alemtuzumab?

A

Recognizes domain on immune cells and signals for cell death by lysis or phagocytosis.